Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Genetic Mutation Could Help Battle Tourette Syndrome

May 6, 2010 7:04 am | News | Comments

A single, very unusual family with Tourette syndrome (TS) has led Yale School of Medicine researchers to identify a rare mutation in a gene that is required to produce histamine.


Brain May Use tPA As Natural Protection Against Stroke

May 6, 2010 6:57 am | News | Comments

New research on the properties of the clot-busting stroke drug tPA (tissue-type plasminogen activator) suggests that tPA can act as a neuroprotectant and may form the keystone of an adaptive response to a reduction in blood flow.


Merck and Ariad Restructure Ridaforolimus Deal

May 6, 2010 6:50 am | News | Comments

Merck and Ariad Pharmaceuticals are restructuring how they develop a potential cancer drug, with Merck saying it will cover all development costs in exchange for worldwide rights to the drug candidate.


Court Rules for Merck in Fosamax Case

May 6, 2010 6:44 am | News | Comments

Drugmaker Merck & Co. says a federal court jury has ruled in its favor in the second trial over whether its osteoporosis drug made teeth and jawbones deteriorate.


FIMM Utilizing Aushon 2470 in Screening Facility

May 6, 2010 6:32 am | News | Comments

Aushon BioSystems, Inc. announced that the Institute for Molecular Medicine Finland (FIMM) will launch a cell microarray screening research program utilizing its 2470 Arrayer technology.


ScreenTape Equal to Accepted RNA Sample QC Techniques

May 6, 2010 6:26 am | News | Comments

In a recently published paper, Lab901’s ScreenTape automated gel electrophoresis system demonstrated equivalence to - and improvements on - the accepted standard measurement of RNA sample quality control prior to microarray analysis.


Informatics Platform

May 5, 2010 7:36 am | Product Releases | Comments

Accelrys, Inc. announced the release of Accelrys Pipeline Pilot 8.0. This latest release of Accelrys’ scientific informatics platform has been further developed to support a greater number of scientists and researchers working individually or as collaborative teams.


Red Fluorescent Dye

May 5, 2010 7:30 am | Product Releases | Comments

VisEn Medical Inc. announced the commercial launch of its new VivoTag 645 red fluorescent dye for optimized labeling of biomolecules in a broad range of in vitro and in vivo research applications.


Harlan Laboratories Elects New CEO

May 5, 2010 7:13 am | News | Comments

Harlan Laboratories, Inc., a leading contract research organization and research models and services company, has elected Hans Thunem the company’s new chief executive officer and board member.


CVS Caremark Profits Rise 4.5%

May 5, 2010 7:09 am | by Marley Seaman | News | Comments

CVS Caremark Corp. said its profit rose 4.5 percent in the first quarter, but said the mild cold and flu season hurt its sales.


Control Mechanism Behind Autoimmune Diseases Discovered

May 5, 2010 7:05 am | News | Comments

Researchers at the Swedish medical university Karolinska Institutet have discovered a new control mechanism in our immune system.


Trauma-Induced Genetic Changes May Lead To PTSD

May 5, 2010 7:01 am | News | Comments

A study at Columbia University's Mailman School of Public Health suggests that traumatic experiences "biologically embed" themselves in select genes, altering their functions and leading to the development of post-traumatic stress disorder.


FDA Approves Vyvanse PI Change

May 5, 2010 6:46 am | News | Comments

Shire plc announced that the US Food and Drug Administration approved a change to the prescribing information for its once-daily Attention Deficit Hyperactivity Disorder (ADHD) treatment, Vyvanse.


InterMune Shares Plummet on Esbriet News

May 5, 2010 6:38 am | by Marley Seaman | News | Comments

Shares of InterMune crashed in premarket trading Wednesday after regulators asked the company to perform additional tests on its lung disease drug Esbriet, potentially delaying its approval by years.


FDA Looking for Ways to Stop DXM Abuse

May 5, 2010 6:32 am | News | Comments

The Food and Drug Administration has scheduled a meeting to discuss ways to curb abuse of a key ingredient found in Robitussin and other cough suppressing medicines.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.